Skip to content

Testing an education programme to help people impacted by cancer assess health information and spot misinformation

Evaluating the feasibility and acceptability of the Informed Health Choices-Cancer programme: a pilot randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17391470
Enrollment
60
Registered
2025-05-08
Start date
2025-05-12
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of harm from health misinformation in people impacted by cancer Cancer

Interventions

• Participants are randomised 1:1 to either an intervention group or a waitlist control group. • The intervention group receives access to the Informed Health Choices–Cancer (IHC-Cancer) programme: an

Sponsors

Ollscoil na Gaillimhe – University of Galway
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years 2. Current patients and survivors – diagnosed with any type of cancer 3. Current patients – person currently undergoing treatment for any type of cancer 4. Survivors – those who have completed treatment and with or without current care/follow-up 5. Informal caregivers – those who provide the majority of unpaid, informal care, and self-identify as informal caregivers for a person diagnosed with cancer 6. Loved ones – family member, friend, or someone who cares about a person diagnosed with cancer, and who self-identifies as a loved one of a person diagnosed with cancer 7. Be able to commit to the study for at least four weeks 8. Can give informed consent 9. Can access the internet

Exclusion criteria

Exclusion criteria: 1. Currently involved in another similar study 2. Irregular and frequently changing caregivers (for informal caregivers)

Design outcomes

Primary

MeasureTime frame
1. Feasibility: Recruitment efficiency, retention, adherence, technical feasibility, and data collection efficacy will be measured using learning platform data, researcher logs and self-reported questionnaire items developed for this study at four weeks post-randomisation. 2. Acceptability: Participation rates, participation burden, participants’ perspectives, and general acceptability will be assessed using self-reported questionnaire items developed for this study at four weeks post-randomisation.

Secondary

MeasureTime frame
1. Critical thinking and decision-making skills will be measured using a scenario-based assessment questionnaire developed for this study at four weeks post-randomisation. 2. eHealth literacy will be measured using the eHealth Literacy Scale (eHEALS) at four weeks post-randomisation. 3. Cognition and behaviour change will be measured using self-reported questionnaire items developed for this study at 4 weeks post-randomisation.

Countries

Ireland

Contacts

Public ContactMengqi Li
m.li10@nuigalway.ie+353 0894950907

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Sep 19, 2026